Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Adenosine can help treat hair loss by promoting hair growth.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

SIG-1451 could be a promising new treatment for atopic dermatitis.

These medications for BPH have known risks and may have new side effects.

Third-generation antihistamines are the safest and most effective for allergies.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

These medications for BPH have known risks and may have new side effects.

Dutasteride is approved to help manage prostate enlargement.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.